Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, March 19 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and... Read More

Singapore Clinical Trial: A multicenter open-label extension study to evaluate long-term safety and efficacy of QCZ484 in hypertensive patients.

Singapore, March 19 -- The Health Sciences Authority received information related to the study titled 'A multicenter open-label extension study to evaluate long-term safety and efficacy of QCZ484 in h... Read More

Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, March 19 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asci... Read More

Singapore Clinical Trial: A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with chemotherapy followed by asciminib plus blinatumomab in pediatric, adolescent, and young adult participants with relapsed or refractory BCR::ABL1-positive (Philadelphia positive, Ph+) or BCR::ABL1-like (Ph-like) acute lymphoblastic leukemia (ALL)

Singapore, March 19 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib wit... Read More

Singapore Clinical Trial: A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC determined ineligible for PD(L)1 therapy based on PD-L1 negative disease

Singapore, March 19 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy... Read More

"It is shameful to make such remarks": IYC chief Uday Bhanu Chib on Kangana Ranaut's 'tapori' remark

New Delhi, March 19 -- Indian Youth Congress National President Uday Bhanu Chib on Wednesday criticised BJP MP Kangana Ranaut over her 'tapori' remark against Leader of Opposition in Lok Sabha Rahul G... Read More

Punjab seeks rRs.r1.44L crore water royalty from Rajasthan

Chandigarh, March 19 -- The Punjab government on Wednesday demanded royalty from neighbouring Rajasthan for water supplied for its irrigation and drinking needs, claiming a staggering outstanding amou... Read More

Shrestha returns with first-hand experience of war in East Asia

Ramechhap, March 19 -- Debendra Kumar Shrestha of Puranagaun in Manthali Municipality-9 in Ramechhap district had an almost first-hand experience of the rising tensions in West Asia while in Dubai. A... Read More

Indian Open Polo Championship: Jaipur Optiemus Achievers edge Jindal Panther 9-6 in rain-hit exhibition match

New Delhi, March 19 -- On a breezy, rain-kissed evening at the iconic Jaipur Polo Grounds, nearly 1,000 spectators braved intermittent showers to witness an entertaining exhibition clash between Jinda... Read More

Rakib's murder 'planned by husband of woman he knew', police say

Dhaka, March 19 -- Police have arrested five suspects in connection with the killing of college student Rakibul Islam Rakib in Dhaka's Central Shaheed Minar area, saying that several of those directly... Read More

• ««
• «
• 7794
• 7795
• 7796
• 7797
• 7798
• 7799
• 7800
• 7801
• 7802
• 7803
• »
• »»